The Oxfordresearchers, withcolleagues at theMDAndersonCancerCenter at the UniversityofTexas, Houston, confirmtheir approach works in results publishedinthe journalPNAS.
"Our study would strongly suggest that it is not beneficial to do it as front-line treatment but to reserve it as second-line or salvage therapy, " said study leader Dr. Mark Gilbert oftheUniversityofTexasMDAndersonCancerCenter in Houston.